Stem Cell Theranostics
A biotechnology company founded in 2013 that develops technology to treat heart disease using pluripotent stem cells. Disease in a dish and clinical trial in a dish platforms are used to develop cardiovascular drugs and perform cardio-toxicity safety testing for non-cardiovascular drugs.
Name
# Contributions
Last Contribution
Find more companies like Stem Cell Theranostics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
